(Total Views: 674)
Posted On: 11/18/2019 4:51:58 AM
Post# of 148936
Second one I posted to ihub
$CYDY now 33c, June 2020 target $2 with first drug approval
Market share US only estimate for combo—-3 Billion Dollars
Company has raised over $200M to get the approval
Why leronlimab is superior? less side effects, weekly dosing, no resistance
$CYDY now 33c, June 2020 target $2 with first drug approval
Market share US only estimate for combo—-3 Billion Dollars
Company has raised over $200M to get the approval
Why leronlimab is superior? less side effects, weekly dosing, no resistance
(5)
(0)Scroll down for more posts ▼
